Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Coric

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Biological Psychiatry|December 5, 2006
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptomsGerard Sanacora, Steven F Kendell, Yael Levin, et al.
Psychiatry (Edgmont (Pa. : Township))|November 25, 2010
Consulting to government agencies-: indirect assessmentsCharles A Morgan, Michael G Gelles, George Steffian, et al.
Headache|May 22, 2021
Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraineEvan Popoff, Karissa Johnston, Robert Croop, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 11, 2008
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic reviewMichael H Bloch, Angeli Landeros-Weisenberger, Srijan Sen, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trialChristopher Pittenger, Michael H Bloch, Suzanne Wasylink, et al.
Pharmacology, Biochemistry, and Behavior|March 22, 2006
Self-reported paranoia during laboratory "binge" cocaine self-administration in humansRasmon Kalayasiri, Atapol Sughondhabirom, Ralitza Gueorguieva, et al.
Comprehensive Psychiatry|April 27, 2013
Sheehan Suicidality Tracking Scale (S-STS): reliability, convergent and discriminative validity in young Italian adultsAntonio Preti, David V Sheehan, Vladimir Coric, et al.
Advances in Therapy|August 29, 2021
Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving RimegepantKarissa M Johnston, Gilbert L'Italien, Evan Popoff, et al.
Psychopharmacology|February 24, 2005
A paradigm to investigate the self-regulation of cocaine administration in humansAtapol Sughondhabirom, Diwakar Jain, Ralitza Gueorguieva, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 21, 2021
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysisKarissa Johnston, Evan Popoff, Alison Deighton, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|December 5, 2006
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptomsGerard Sanacora, Steven F Kendell, Yael Levin, et al.
Psychiatry (Edgmont (Pa. : Township))|November 25, 2010
Consulting to government agencies-: indirect assessmentsCharles A Morgan, Michael G Gelles, George Steffian, et al.
Headache|May 22, 2021
Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraineEvan Popoff, Karissa Johnston, Robert Croop, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 11, 2008
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic reviewMichael H Bloch, Angeli Landeros-Weisenberger, Srijan Sen, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trialChristopher Pittenger, Michael H Bloch, Suzanne Wasylink, et al.
Pharmacology, Biochemistry, and Behavior|March 22, 2006
Self-reported paranoia during laboratory "binge" cocaine self-administration in humansRasmon Kalayasiri, Atapol Sughondhabirom, Ralitza Gueorguieva, et al.
Comprehensive Psychiatry|April 27, 2013
Sheehan Suicidality Tracking Scale (S-STS): reliability, convergent and discriminative validity in young Italian adultsAntonio Preti, David V Sheehan, Vladimir Coric, et al.
Advances in Therapy|August 29, 2021
Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving RimegepantKarissa M Johnston, Gilbert L'Italien, Evan Popoff, et al.
Psychopharmacology|February 24, 2005
A paradigm to investigate the self-regulation of cocaine administration in humansAtapol Sughondhabirom, Diwakar Jain, Ralitza Gueorguieva, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 21, 2021
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysisKarissa Johnston, Evan Popoff, Alison Deighton, et al.
Pageof 9